The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.
Edwards Lifesciences' risk factor disclosures shifted from prospective concerns about completing the Critical Care spin-off to realized risks associated with executing the sale, with two spin-off related risks removed and replaced by risks tied to the actual divestiture and heightened data privacy compliance obligations. The company expanded its cybersecurity and IT infrastructure risk disclosure among its four substantively modified risk factors, reflecting increased emphasis on operational resilience. With 18 risks remaining unchanged, Edwards maintained consistent disclosure of established business challenges while recalibrating its structural risk narrative to align with the company's transition from planned separation to active divestiture.
Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.
🟢 New in Current Filing
We are subject to risks associated with the sale of our Critical Care product group.
🔒
🟢 New in Current Filing
Failure to comply with data privacy and security laws could have a material adverse effect on our business.
🔒
🔴 No Match in Current Filing
We may not be able to complete the announced spin-off of our Critical Care product group at all, or within the timeframes we anticipate, or pursuant to the tax-free structure that we anticipate, and we may not realize some or all of the expected benefits of this transaction.
🔒
🔴 No Match in Current Filing
Assuming the spin-off is successfully completed, the newly spun-off Critical Care company as a standalone public company may not deliver the returns that we or the shareholders anticipate.
🔒
🟡 Modified
Summary of Risk Factors
🔒
🟡 Modified
Failure to protect our information technology infrastructure and our products against cybersecurity attacks, network security breaches, service interruptions, or data corruption could materially disrupt our operations and adversely affect our business and operating results.
🔒
🟡 Modified
The success of many of our products depends upon certain key physicians, research institutions, and hospital systems.
🔒
🟡 Modified
Failure to successfully integrate acquired businesses, technologies or strategic alliances, or challenges related to the execution of acquisitions or divestitures, as well as liabilities or claims relating to such acquired businesses or divestitures, could adversely affect our business and results of operations.
🔒